Regis Healthcare Management
Management criteria checks 4/4
Regis Healthcare's CEO is Linda Mellors, appointed in Sep 2019, has a tenure of 5.67 years. total yearly compensation is A$1.66M, comprised of 47.5% salary and 52.5% bonuses, including company stock and options. directly owns 0.094% of the company’s shares, worth A$2.21M. The average tenure of the management team and the board of directors is 4.6 years and 6.4 years respectively.
Key information
Linda Mellors
Chief executive officer
AU$1.7m
Total compensation
| CEO salary percentage | 47.46% |
| CEO tenure | 5.7yrs |
| CEO ownership | 0.09% |
| Management average tenure | 4.6yrs |
| Board average tenure | 6.4yrs |
Recent management updates
Recent updates
Take Care Before Diving Into The Deep End On Regis Healthcare Limited (ASX:REG)
Apr 07
Investor Optimism Abounds Regis Healthcare Limited (ASX:REG) But Growth Is Lacking
Dec 20Regis Healthcare Limited's (ASX:REG) P/S Is Still On The Mark Following 31% Share Price Bounce
Sep 12Is There An Opportunity With Regis Healthcare Limited's (ASX:REG) 38% Undervaluation?
May 02At AU$3.94, Is It Time To Put Regis Healthcare Limited (ASX:REG) On Your Watch List?
Mar 21Regis Healthcare (ASX:REG) Has Announced A Dividend Of A$0.0628
Feb 28Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why
Oct 18Regis Healthcare (ASX:REG) Is Paying Out A Larger Dividend Than Last Year
Aug 29Regis Healthcare (ASX:REG) Is Paying Out Less In Dividends Than Last Year
Mar 01Is Regis Healthcare (ASX:REG) Using Debt Sensibly?
Oct 27Regis Healthcare's (ASX:REG) Shareholders Will Receive A Smaller Dividend Than Last Year
Aug 26Regis Healthcare Limited's (ASX:REG) Intrinsic Value Is Potentially 34% Above Its Share Price
Feb 25Is Regis Healthcare Limited (ASX:REG) Potentially Undervalued?
May 27Estimating The Fair Value Of Regis Healthcare Limited (ASX:REG)
May 09Should You Be Excited About Regis Healthcare Limited's (ASX:REG) 23% Return On Equity?
Aug 10At AU$1.32, Is Regis Healthcare Limited (ASX:REG) Worth Looking At Closely?
Aug 10Reflecting on Regis Healthcare's (ASX:REG) Share Price Returns Over The Last Five Years
Jul 14Is Regis Healthcare Limited (ASX:REG) An Attractive Dividend Stock?
Jul 02CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2024 | n/a | n/a | AU$15m |
| Sep 30 2024 | n/a | n/a | -AU$3m |
| Jun 30 2024 | AU$2m | AU$789k | -AU$21m |
| Mar 31 2024 | n/a | n/a | -AU$18m |
| Dec 31 2023 | n/a | n/a | -AU$15m |
| Sep 30 2023 | n/a | n/a | -AU$22m |
| Jun 30 2023 | AU$1m | AU$755k | -AU$28m |
| Mar 31 2023 | n/a | n/a | -AU$45m |
| Dec 31 2022 | n/a | n/a | -AU$61m |
| Sep 30 2022 | n/a | n/a | -AU$50m |
| Jun 30 2022 | AU$952k | AU$711k | -AU$39m |
| Mar 31 2022 | n/a | n/a | -AU$16m |
| Dec 31 2021 | n/a | n/a | AU$8m |
| Sep 30 2021 | n/a | n/a | AU$14m |
| Jun 30 2021 | AU$767k | AU$698k | AU$20m |
| Mar 31 2021 | n/a | n/a | AU$8m |
| Dec 31 2020 | n/a | n/a | -AU$4m |
| Sep 30 2020 | n/a | n/a | -AU$2m |
| Jun 30 2020 | AU$729k | AU$643k | -AU$716k |
Compensation vs Market: Linda's total compensation ($USD1.07M) is about average for companies of similar size in the Australian market ($USD1.29M).
Compensation vs Earnings: Linda's compensation has been consistent with company performance over the past year.
CEO
Linda Mellors
Dr. Linda Jane Mellors, B.A., B.Sc. (Hons), Ph.D. (Med) GAICD, Grad Cert HSM, has been Chief Executive Officer of Regis Healthcare Limited since September 4, 2019 and serves as its Managing Director and Di...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Director | 5.7yrs | AU$1.66m | 0.094% A$ 2.2m | |
| Chief Financial Officer | 5.2yrs | AU$1.19m | 0.028% A$ 644.8k | |
| Chief Information Officer | 4.6yrs | no data | no data | |
| General Counsel & Company Secretary | 3.5yrs | no data | no data | |
| Chief People Officer | 1.3yrs | no data | no data |
Experienced Management: REG's management team is considered experienced (4.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Director | 5.7yrs | AU$1.66m | 0.094% A$ 2.2m | |
| Independent Non-Executive Chairman | 7.8yrs | AU$289.23k | 0.037% A$ 855.7k | |
| Independent Non-Executive Director | 7.2yrs | AU$189.23k | 0.027% A$ 641.9k | |
| Non-Executive Director | 10.6yrs | AU$169.23k | 27.2% A$ 637.4m | |
| Independent Non-Executive Director | 1.5yrs | AU$97.69k | 0.0070% A$ 165.0k | |
| Independent Non-Executive Director | 3.3yrs | AU$189.23k | 0.010% A$ 233.4k |
Experienced Board: REG's board of directors are considered experienced (6.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/22 06:24 |
| End of Day Share Price | 2025/05/22 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Regis Healthcare Limited is covered by 17 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| William Dunlop | BofA Global Research |
| David Stanton | CLSA |
| David Low | Deutsche Bank |